Literature DB >> 11744830

Evaluation of immune activation in HIV-infected and uninfected African individuals by single-cell analysis of cytokine production.

M Lukwiya1, G Rizzardini, D Trabattoni, S Piconi, M Saresella, S Declich, S Fossati, M Clerici.   

Abstract

Immune activation has been observed in HIV-infected and uninfected Africans, among whom it is thought to modify interaction between the immune system and HIV. To characterize this phenomenon accurately, in-depth immunologic analyses were performed in a rural African population. Freshly drawn peripheral blood mononuclear cells (PBMCs) of HIV-infected African (from Gulu, Uganda) and Italian antiviral-naive patients and those of uninfected Ugandan and Italian study subjects were analyzed. Individuals were matched for age and sex and determined to be free from parasitic infections. Intracellular cytokines were measured in mitogen (M)- and gp160 peptides + staphylococcal enterotoxin B and alpha CD28 (env)-stimulated T lymphocytes. Interferon (IFN)-gamma-producing CD8(+) T cells were quantified in an enzyme-linked immunosorbent assay. Results showed that M-stimulated production of interleukin (IL)-10 and tumor necrosis factor (TNF)-alpha increases in CD4(+) and CD8(+) cells of African infected patients and uninfected study subject; and that env-stimulated IL-10 and TNF-alpha production is increased in CD8(+) T lymphocytes of African HIV-infected patients. M- and env-stimulated IFN-gamma-producing CD8(+) T cells were reduced in African participants and not increased by preincubation with alpha IL-10 monoclonal antibody. This is the first set of data that has reported immune activation in rural Africa by single-cell analysis of cytokine production. These results help in defining the immunologic background to be considered in the design of therapeutic and vaccine-based approaches to HIV infection in an African setting.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744830     DOI: 10.1097/00042560-200112150-00004

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  5 in total

1.  Dynamics of simian immunodeficiency virus SIVmac239 infection in pigtail macaques.

Authors:  Nichole R Klatt; Lauren A Canary; Thomas H Vanderford; Carol L Vinton; Jessica C Engram; Richard M Dunham; Heather E Cronise; Joanna M Swerczek; Bernard A P Lafont; Louis J Picker; Guido Silvestri; Jason M Brenchley
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

2.  Elevation of immune activation in kenyan women is associated with alterations in immune function: implications for vaccine development.

Authors:  Sandra A Koesters; Lucy Matu; Peter Kiama; Omu Anzala; Joanne Embree; Francis A Plummer; Joshua Kimani; Keith R Fowke
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

3.  Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does not protect against disease progression.

Authors:  Jérôme Feldmann; Aleksandra Leligdowicz; Assan Jaye; Tao Dong; Hilton Whittle; Sarah L Rowland-Jones
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

4.  High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi.

Authors:  Amy Y Liu; Stephen C De Rosa; Brandon L Guthrie; Robert Y Choi; Rose Kerubo-Bosire; Barbra A Richardson; James Kiarie; Carey Farquhar; Barbara Lohman-Payne
Journal:  Immun Inflamm Dis       Date:  2018-07-04

5.  Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients.

Authors:  Adithya Cattamanchi; Isaac Ssewenyana; Rose Nabatanzi; Cecily R Miller; Saskia Den Boon; J Lucian Davis; Alfred Andama; William Worodria; Samuel D Yoo; Huyen Cao; Laurence Huang
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.